DCF — CARILION NEW RIVER VALLEY MED CENTER
Enterprise Value: $-67.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-67.4M
Enterprise Value
$-28.5M
PV of Cash Flows
$-38.9M
PV of Terminal Value
$-62.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $269.2M | $0.1M | 0.0% | $-11.3M | $-10.3M |
| Year 2 | $277.2M | $2.9M | 1.0% | $-8.8M | $-7.3M |
| Year 3 | $285.6M | $5.8M | 2.0% | $-6.3M | $-4.7M |
| Year 4 | $294.1M | $7.5M | 3.0% | $-5.0M | $-3.4M |
| Year 5 | $302.9M | $8.5M | 3.0% | $-4.6M | $-2.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-67.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$261.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.00456544359854675
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5